Drug Shortage Report for SODIUM CHLORIDE INJECTION, USP
| Report ID | 250996 |
| Drug Identification Number | 02139510 |
| Brand name | SODIUM CHLORIDE INJECTION, USP |
| Common or Proper name | SODIUM CHLORIDE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM CHLORIDE |
| Strength(s) | 234MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 200mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-03-06 |
| Actual start date | |
| Estimated end date | 2025-04-01 |
| Actual end date | 2025-04-02 |
| Shortage status | Resolved |
| Updated date | 2025-04-03 |
| Company comments | Fresenius Kabi Canada regrets to advise that we will be encountering a supply interruption on our Sodium Chloride Injection, USP 4 mmol/mL PBV 200 mL effective March 6, 2025, until April 1, 2025. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-04-03 | English | Compare |
| v5 | 2025-03-28 | French | Compare |
| v4 | 2025-03-28 | English | Compare |
| v3 | 2025-03-07 | English | Compare |
| v2 | 2025-02-21 | French | Compare |
| v1 | 2025-02-21 | English | Compare |
Showing 1 to 6 of 6